Skip to main navigation Skip to search Skip to main content

Market licensing of type 2 diabetes medicinal products based on patient-relevant hard outcomes: is there hope?

1 Citation (Scopus)
Original languageEnglish
JournalEuropean heart journal. Cardiovascular pharmacotherapy
Volume4
Issue number1
Pages (from-to)4-5
Number of pages2
ISSN2055-6837
DOIs
Publication statusPublished - 1 Jan 2018
Externally publishedYes

Keywords

  • Diabetes Mellitus, Type 2
  • Drug Approval
  • European Union
  • Hope
  • Humans
  • Legislation, Drug
  • Licensure
  • Phytotherapy
  • Plants, Medicinal
  • Treatment Outcome

Cite this